Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

23.10.22	ABT APPROACHING DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses Over $100K to Secure Counsel Before Important October 31 Deadline in Securities Cl... (PR Newswire)
19.10.22	Abbott Laboratories Boosts FY22 Outlook - Update (RTTNews)
19.10.22	Abbott Laboratories Q3 Profit Decreases, but beats estimates (RTTNews)
19.10.22	Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance (PR Newswire)
17.10.22	Abbott Recalls Certain Ready-to-Feed Liquid Products (RTTNews)
15.10.22	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT (PR Newswire)
12.10.22	Abbott and The Home Edit Redesign the Medicine Cabinet to Help People Prepare for the Upcoming Virus Season (PR Newswire)
08.10.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
06.10.22	New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life (PR Newswire)
28.09.22	ROSEN, A LONGSTANDING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
28.09.22	Abbott Hosts Conference Call for Third-Quarter Earnings (PR Newswire)
17.09.22	ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
17.09.22	Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies (PR Newswire)
15.09.22	Abbott Declares 395th Consecutive Quarterly Dividend (PR Newswire)
12.09.22	ABT INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
08.09.22	Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery (PR Newswire)
04.09.22	ROSEN, A LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
29.08.22	Abbott: Study Shows HeartMate 3 Pump Extends Life Expectancy Of Advanced Heart Failure Patients (RTTNews)
29.08.22	New Data Show Abbott's HeartMate 3™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients (PR Newswire)
23.08.22	Abbott Announces FDA Approval For Its Proclaim Plus Spinal Cord Stimulation System (RTTNews)
23.08.22	FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions (PR Newswire)
11.08.22	Abbott: Research Shows TBI Blood Test Helpful In Predicting Recovery From Traumatic Brain Injury (RTTNews)
11.08.22	New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions (PR Newswire)
04.08.22	Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals (PR Newswire)
26.07.22	Abbott Unveils NeuroSphere Virtual Clinic In Canada (RTTNews)
21.07.22	ABT Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6% (RTTNews)
20.07.22	Abbott Q2 Profit Tops Estimates; Raises 2022 Earnings Guidance (RTTNews)
20.07.22	Abbott Laboratories Q2 Profit Increases, beats estimates (RTTNews)
20.07.22	Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance (PR Newswire)
12.07.22	Abbott: FDA Grants Breakthrough Device Designation To Investigate DBS System In TRD (RTTNews)
12.07.22	Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression (PR Newswire)
11.07.22	US To Import 4.9 Mln Cans Of Baby Formula From Australia (RTTNews)
01.07.22	US To Import 17 Mln Bottles Of Infant Formula From New Zealand, Ireland (RTTNews)
29.06.22	Abbott Hosts Conference Call for Second-Quarter Earnings (PR Newswire)
23.06.22	FDA Probes Death Of Infant Who Consumed Abbott Infant Formula (RTTNews)
10.06.22	Abbott Declares 394th Consecutive Quarterly Dividend (PR Newswire)
06.06.22	Abbott Restarts Baby Formula Production At Michigan Plant (RTTNews)
06.06.22	Abbott Says Data Show FreeStyle Libre 3 System Most Accurate 14-Day Continuous Glucose Monitor (RTTNews)
05.06.22	Late-Breaking Data Demonstrate Abbott's FreeStyle Libre® 3 System is Most Accurate 14-Day Continuous Glucose Monitor (PR Newswire)
03.06.22	Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System (PR Newswire)
31.05.22	Abbott Says FDA Oks FreeStyle Libre 3 System As Glucose Monitor For Diabetic Patients (RTTNews)
31.05.22	Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor (PR Newswire)
25.05.22	US To Get About 2 Mln Infant Formula Cans From UK's Kendal Nutricare: FDA (RTTNews)
24.05.22	Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need (PR Newswire)
19.05.22	Abbott Presents Data Reinforcing Impact Of Its Minimally Invasive Heart Devices (RTTNews)
19.05.22	New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies (PR Newswire)
17.05.22	Abbott Reaches Agreement With FDA To Restart Baby Formula Production Amid U.S. Shortage (RTTNews)
16.05.22	Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility (PR Newswire)
11.05.22	Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials (PR Newswire)
04.05.22	Abbott Gets FDA Clearance For Alinity M STI Assay Test - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Börse New York in Grün: So steht der NASDAQ 100 aktuell
20.12.24		SPI-Handel aktuell: SPI zum Handelsende leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Börse New York in Grün: So steht der NASDAQ 100 aktuell

20.12.24

SPI-Handel aktuell: SPI zum Handelsende leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten